San Francisco, CA, United States of America

Ursula Jeffry

This inventor holds 1 USPTO granted patent. Top assignee: Five Prime Therapeutics, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ursula Jeffry. Retrieved from https://idiyas.com/inventor/ursula-jeffry-8uc65aw9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ursula Jeffry

Introduction

Ursula Jeffry is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in cancer treatment. Her work focuses on the use of CD80 extracellular domain polypeptides, which have the potential to enhance cancer therapies.

Latest Patents

Ursula holds a patent for "Methods of treatment with CD80 extracellular domain polypeptides." This application relates to the use of CD80 (B7-1) extracellular domain (ECD) polypeptides and CD80-ECD fusion molecules. These innovations are aimed at increasing the number of central memory T cells and improving treatment options for cancer, including their application in cancer vaccine compositions. She has 1 patent to her name.

Career Highlights

Ursula is currently employed at Five Prime Therapeutics, Inc., where she continues to advance her research in immunotherapy. Her work has been instrumental in developing new strategies for cancer treatment, showcasing her dedication to improving patient outcomes.

Collaborations

Ursula collaborates with various professionals in her field, including her coworker Barbara Sennino. Together, they work on innovative solutions that aim to revolutionize cancer treatment.

Conclusion

Ursula Jeffry's contributions to biotechnology and cancer treatment highlight her role as a pioneering inventor. Her innovative approaches and dedication to research continue to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…